Sarecycline: A Narrow-Spectrum Antibiotic.

Abstract

Tetracycline-class drugs have been used for first-line treatment of moderate-to-severe acne and rosacea for decades. Recently, a new third generation tetracycline, sarecycline, was US FDA-approved for the treatment of moderate-to-severe acne. This narrow-spectrum tetracycline-derived antibiotic has been shown to be effective with an improved safety profile.

• Authors: Susuana Adjei, Austinn C Miller, Laurie A Temiz, Stephen K Tyring
• Journal: Skin therapy letter (Skin Therapy Lett) Vol. 27 Issue 3 Pg. 5-7 (May 2022) ISSN: 1201-5989 [Print] Canada
• PMID: 35533371 (Publication Type: Journal Article)

Chemical References

• Anti-Bacterial Agents
• Protein Synthesis Inhibitors
• Tetracyclines
• sarecycline
• Tetracycline

Topics

• Acne Vulgaris (drug therapy)
• Anti-Bacterial Agents (adverse effects)
• Humans
• Protein Synthesis Inhibitors (therapeutic use)
• Tetracycline (therapeutic use)
• Tetracyclines (therapeutic use)